Regadenoson bulk supplier for pharma manufacturers

Regadenoson 0.4 mg/5 mL Suppliers & Bulk Manufacturers

Available Forms: injection (prefilled syringe)

Available Strengths: 0.4 mg/5 mL

Reference Brands: Lexiscan (USA)

Regadenoson is a Critical Care product available as injection (prefilled syringe) in strengths 0.4 mg/5 mL. It corresponds to the reference brand Lexiscan (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Regadenoson is a selective A2A adenosine receptor agonist used as a pharmacologic stress agent in myocardial perfusion imaging (MPI) for the evaluation of coronary artery disease. It is primarily indicated for patients who are unable to perform adequate exercise-based stress testing. By selectively activating the A2A adenosine receptors in coronary arteries, Regadenoson induces rapid and controlled coronary vasodilation, leading to increased coronary blood flow and enhanced myocardial perfusion for accurate radionuclide imaging.

Compared to non-selective agents such as adenosine, Regadenoson offers improved tolerability due to its high selectivity for the A2A receptor. It has minimal activity at A1 receptors and negligible affinity for A2B and A3 receptors, which significantly reduces the incidence of undesirable side effects like bronchoconstriction, atrioventricular block, and severe hypotension. Regadenoson also has a longer half-life than adenosine, allowing sustained hyperemia with a single intravenous bolus administration.

Because of its predictable pharmacologic profile, ease of administration, and favorable safety characteristics, Regadenoson has become a preferred agent in nuclear cardiology for pharmacologic stress testing and myocardial perfusion imaging in both clinical and diagnostic settings.

Regadenoson — third party manufacturing & bulk supply

Regadenoson 0.4 mg/5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Regadenoson is supplied as injection (prefilled syringe) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Regadenoson listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Regadenoson →

Back to Listing

Frequently Asked Questions

Regadenoson is used as a pharmacologic stress agent during myocardial perfusion imaging (MPI) to evaluate coronary artery disease in patients who are unable to perform adequate physical exercise stress testing.

Regadenoson is a synthetic selective adenosine A2A receptor agonist. It is a chemically synthesized compound designed to cause coronary vasodilation without significant effects on other adenosine receptors.

The most widely recognized trade name of Regadenoson is Lexiscan.

Lexiscan (Regadenoson injection) is manufactured and marketed by Astellas Pharma in regulated markets such as the USA. Generic versions are also produced by other approved pharmaceutical manufacturers.

The generic name of the product is regadenoson.

The brand name of Regadenoson is Lexiscan.

Regadenoson injection is manufactured in FDA- and EU-approved facilities located in countries such as the USA, Europe, and other regions, depending on the brand or generic manufacturer.